Nancy Iturria

2.0k total citations
12 papers, 1.5k citations indexed

About

Nancy Iturria is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Nancy Iturria has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Nancy Iturria's work include Glioma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Nancy Iturria is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Nancy Iturria collaborates with scholars based in United States, Romania and Spain. Nancy Iturria's co-authors include Judith R. OʼFallon, Jan C. Buckner, Rafaël Fonseca, Morie A. Gertz, John A. Lust, Thomas E. Witzig, Susan M. Geyer, Robert A. Kyle, Martha Q. Lacy and S. Vincent Rajkumar and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Nancy Iturria

12 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Iturria United States 8 779 661 625 519 313 12 1.5k
Kirsten van Lom Netherlands 25 539 0.7× 427 0.6× 579 0.9× 326 0.6× 114 0.4× 47 1.5k
Matthew Christopher United States 11 583 0.7× 549 0.8× 1.2k 1.9× 537 1.0× 153 0.5× 24 2.2k
Holger Nückel Germany 27 535 0.7× 810 1.2× 218 0.3× 426 0.8× 150 0.5× 59 1.9k
Ann M. Lowe United States 9 414 0.5× 579 0.9× 252 0.4× 253 0.5× 174 0.6× 11 1.4k
August J. Salvado United States 13 291 0.4× 523 0.8× 350 0.6× 153 0.3× 147 0.5× 37 885
Kevin S. Choe United States 15 352 0.5× 186 0.3× 188 0.3× 314 0.6× 271 0.9× 31 1.0k
Norman M. Law United States 6 302 0.4× 300 0.5× 550 0.9× 215 0.4× 289 0.9× 9 1.1k
Carles Besses Spain 22 780 1.0× 965 1.5× 680 1.1× 161 0.3× 62 0.2× 66 1.5k
Amy J. Zigler United States 7 278 0.4× 233 0.4× 415 0.7× 163 0.3× 271 0.9× 8 1.0k
Andreas Hüttmann Germany 21 367 0.5× 449 0.7× 467 0.7× 523 1.0× 139 0.4× 66 1.7k

Countries citing papers authored by Nancy Iturria

Since Specialization
Citations

This map shows the geographic impact of Nancy Iturria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Iturria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Iturria more than expected).

Fields of papers citing papers by Nancy Iturria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Iturria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Iturria. The network helps show where Nancy Iturria may publish in the future.

Co-authorship network of co-authors of Nancy Iturria

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Iturria. A scholar is included among the top collaborators of Nancy Iturria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Iturria. Nancy Iturria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zimmermann, Annamaria H., Tudor–Eliade Ciuleanu, Paul A. Bunn, et al.. (2016). Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer. Lung Cancer. 104. 45–51. 6 indexed citations
2.
Paz‐Ares, Luis, Annamaria H. Zimmermann, Tudor–Eliade Ciuleanu, et al.. (2014). Meta-analysis examining impact of age on pemetrexed (pem) efficacy for the treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 32(15_suppl). e19040–e19040. 1 indexed citations
3.
Paz‐Ares, Luis, Tudor–Eliade Ciuleanu, P. A. Bunn, et al.. (2014). Meta-Analysis Examining Impact of Age on Pemetrexed (pem) Efficacy for the Treatment of Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics. 90(5). S43–S43. 1 indexed citations
4.
Brown, Paul D., Jan C. Buckner, Judith R. OʼFallon, et al.. (2004). Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. International Journal of Radiation Oncology*Biology*Physics. 59(1). 117–125. 56 indexed citations
5.
Brown, Paul D., Jan C. Buckner, Judith R. OʼFallon, et al.. (2004). Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. International Journal of Radiation Oncology*Biology*Physics. 58(4). 1153–1160. 58 indexed citations
6.
Kumar, Shaji, Morie A. Gertz, Angela Dispenzieri, et al.. (2003). Response Rate, Durability of Response, and Survival After Thalidomide Therapy for Relapsed Multiple Myeloma. Mayo Clinic Proceedings. 78(1). 34–39. 102 indexed citations
7.
Rajkumar, S. Vincent, Morie A. Gertz, Martha Q. Lacy, et al.. (2003). Thalidomide as initial therapy for early-stage myeloma. Leukemia. 17(4). 775–779. 175 indexed citations
8.
Lahn, Michael, Patrick Peterson, Nancy Iturria, & Karen Sundell. (2003). P-194 Meta-analysis of infection during continuous infusion chemotherapy with minimal infusate changes. Lung Cancer. 41. S140–S140. 1 indexed citations
9.
Brown, Paul D., Jan C. Buckner, Judith R. OʼFallon, et al.. (2003). Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination. Journal of Clinical Oncology. 21(13). 2519–2524. 178 indexed citations
10.
Kuriyama, Hiroko, Kathleen R. Lamborn, Judith R. OʼFallon, et al.. (2002). Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro-Oncology. 4(3). 179–186. 35 indexed citations
11.
Rajkumar, S. Vincent, Suzanne R. Hayman, Morie A. Gertz, et al.. (2002). Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma. Journal of Clinical Oncology. 20(21). 4319–4323. 413 indexed citations
12.
Smith, Justin S., Issei Tachibana, Sandra Passe, et al.. (2001). PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme. JNCI Journal of the National Cancer Institute. 93(16). 1246–1256. 493 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026